Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders (vol 5, pg 708, 2007)

被引：0
|
作者：
De Stefano, V.
Fiorini, A.
Rossi, E.
Za, T.
Farina, G.
Chiusolo, P.
Sica, S.
Leone, G.
机构：
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2008年 / 143卷 / 03期
关键词：
D O I：
10.1111/j.1365-2141.2008.07406.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：451 / 451
页数：1
相关论文
共 50 条
  • [1] Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders
    De Stefano, V.
    Fiorini, A.
    Rossi, E.
    Za, T.
    Farina, G.
    Chiusolo, P.
    Sica, S.
    Leone, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (04) : 708 - 714
  • [2] The V617F JAK 2 mutation is not a frequent event in patients with cerebral venous thrombosis without overt chronic myeloproliferative disorder
    Bellucci, Sylvia
    Cassinat, Bruno
    Bonnin, Nadine
    Marzac, Christophe
    Crassard, Isabelle
    THROMBOSIS AND HAEMOSTASIS, 2008, 99 (06) : 1119 - 1120
  • [3] Prevalence of overt myeloproliferative neoplasms and JAK2 V617F mutation in Korean patients with splanchnic vein thrombosis
    Yoo, E. -H.
    Jang, J. -H.
    Park, K. -J.
    Gwak, G. -Y.
    Kim, H. -J.
    Kim, S. -H.
    Kim, D. -K.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2011, 33 (05) : 471 - 476
  • [4] Incidence and significance of the JAK2 V617F mutation in patients with chronic myeloproliferative disorders
    Langabeer, S. E.
    Ainle, F. Ni
    Conneally, E.
    Lawler, M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2007, 176 (02) : 105 - 109
  • [5] Incidence and significance of the JAK2 V617F mutation in patients with chronic myeloproliferative disorders
    S. E. Langabeer
    F. Ni Ainle
    E. Conneally
    M. Lawler
    Irish Journal of Medical Science, 2007, 176 : 105 - 109
  • [6] JAK2 (V617F) mutation in patients with chronic myeloproliferative disorders
    Hamidah, N.
    Farisah, N.
    Jalil, N.
    Fei-Liang, W.
    AWahid, F.
    Othman, A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 : 121 - 122
  • [7] The JAK2 V617F mutation in patients with cerebral venous thrombosis
    Passamonti, S. M.
    Biguzzi, E.
    Cazzola, M.
    Franchi, F.
    Gianniello, F.
    Bucciarelli, P.
    Pietra, D.
    Mannucci, P. M.
    Martinelli, I.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (06) : 998 - 1003
  • [8] Absence of the JAK2 V617F mutation in patients with arterial thrombosis without overt myeloproliferative disease
    Smalberg, J. H.
    De Maat, M. P. M.
    Leebeek, F. W. G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (09) : 1606 - 1607
  • [9] Janus kinase (JAK) 2 V617F mutation in Asian Indians with cerebral venous thrombosis and without overt myeloproliferative disorders
    De, Tanima
    Prabhakar, Puttachandra
    Nagaraja, Dindagur
    Christopher, Rita
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2012, 323 (1-2) : 178 - 182
  • [10] THE V617F JAK 2 MUTATION IS NOT A FREQUENT EVENT IN PATIENTS WITH CEREBRAL VENOUS THROMBOSIS WITHOUT OVERT CHRONIC MYELOPROLIFERATIVE DISORDER (MPD)
    Bellucci, S.
    Cassinat, B.
    Bonnin, N.
    Marzac, C.
    Crassard, I.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 301 - 301
12345